 |
인쇄하기
취소
|
Dong-A sues Poolim Pharm over Stillen patent
Dong-A Pharmaceutical is suing Poonglim Pharmaceutical for violating its patent rights of Stillen, one of Dong-A’s flagship products for treatment of gastritis.
Dong-A said Thursday Poonglim has violated patent rights by producing Stillen, of which the main ingredient is the same as that in Dong-A's popular drug.
Dong-A claims its patent to be effective until July 2015, warning of litigat...
Dong-A said Thursday Poonglim has violated patent rights by producing Stillen, of which the main ingredient is the same as that in Dong-A's popular drug.
Dong-A claims its patent to be effective until July 2015, warning of litigat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.